In this article, I will discuss everything about the C rating and its meaning for LiPo batteries
Cellular interplay as a consequence of inflammatory signals leading to liver fibrosis development
New program pairs microdoses of GLP-1 medication with Nooms powerful behavior-change program and at-home biomarker testing to track the health impact of combining GLP-1 therapy with healthy habits
Zepbound offers a scientific approach to weight loss that complements lifestyle adjustments, helping you achieve and maintain your health goals
News provided by Ro Apr 09, 2026, 07:15 ET Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary NEW YORK, April 9, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Company's newest oral GLP-1 innovation on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s